A new mouse esophageal cancer cell line (mEC25)‐derived pre‐clinical syngeneic tumor model for immunotherapy

Bibliographic Details
Main Authors: Tuxiong Huang, Jiao Yang, Beilei Liu, Li Fu
Format: Article
Language:English
Published: Wiley 2020-07-01
Series:Cancer Communications
Subjects:
Online Access:https://doi.org/10.1002/cac2.12066
id doaj-5f70b490c9f448a886e58c2f5d9efac2
record_format Article
spelling doaj-5f70b490c9f448a886e58c2f5d9efac22020-11-25T03:01:18ZengWileyCancer Communications2523-35482020-07-0140731632010.1002/cac2.12066A new mouse esophageal cancer cell line (mEC25)‐derived pre‐clinical syngeneic tumor model for immunotherapyTuxiong Huang0Jiao Yang1Beilei Liu2Li Fu3Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Department of Pharmacology and Shenzhen University International Cancer Center Shenzhen University Health Science Center Shenzhen Guangdong 518037 P. R. ChinaGuangdong Provincial Key Laboratory of Regional Immunity and Diseases, Department of Pharmacology and Shenzhen University International Cancer Center Shenzhen University Health Science Center Shenzhen Guangdong 518037 P. R. ChinaDepartment of Clinical Oncology the University of Hong Kong Hong Kong 999077 P. R. ChinaGuangdong Provincial Key Laboratory of Regional Immunity and Diseases, Department of Pharmacology and Shenzhen University International Cancer Center Shenzhen University Health Science Center Shenzhen Guangdong 518037 P. R. Chinahttps://doi.org/10.1002/cac2.12066esophageal cancerimmunotherapysyngeneic mouse model
collection DOAJ
language English
format Article
sources DOAJ
author Tuxiong Huang
Jiao Yang
Beilei Liu
Li Fu
spellingShingle Tuxiong Huang
Jiao Yang
Beilei Liu
Li Fu
A new mouse esophageal cancer cell line (mEC25)‐derived pre‐clinical syngeneic tumor model for immunotherapy
Cancer Communications
esophageal cancer
immunotherapy
syngeneic mouse model
author_facet Tuxiong Huang
Jiao Yang
Beilei Liu
Li Fu
author_sort Tuxiong Huang
title A new mouse esophageal cancer cell line (mEC25)‐derived pre‐clinical syngeneic tumor model for immunotherapy
title_short A new mouse esophageal cancer cell line (mEC25)‐derived pre‐clinical syngeneic tumor model for immunotherapy
title_full A new mouse esophageal cancer cell line (mEC25)‐derived pre‐clinical syngeneic tumor model for immunotherapy
title_fullStr A new mouse esophageal cancer cell line (mEC25)‐derived pre‐clinical syngeneic tumor model for immunotherapy
title_full_unstemmed A new mouse esophageal cancer cell line (mEC25)‐derived pre‐clinical syngeneic tumor model for immunotherapy
title_sort new mouse esophageal cancer cell line (mec25)‐derived pre‐clinical syngeneic tumor model for immunotherapy
publisher Wiley
series Cancer Communications
issn 2523-3548
publishDate 2020-07-01
topic esophageal cancer
immunotherapy
syngeneic mouse model
url https://doi.org/10.1002/cac2.12066
work_keys_str_mv AT tuxionghuang anewmouseesophagealcancercelllinemec25derivedpreclinicalsyngeneictumormodelforimmunotherapy
AT jiaoyang anewmouseesophagealcancercelllinemec25derivedpreclinicalsyngeneictumormodelforimmunotherapy
AT beileiliu anewmouseesophagealcancercelllinemec25derivedpreclinicalsyngeneictumormodelforimmunotherapy
AT lifu anewmouseesophagealcancercelllinemec25derivedpreclinicalsyngeneictumormodelforimmunotherapy
AT tuxionghuang newmouseesophagealcancercelllinemec25derivedpreclinicalsyngeneictumormodelforimmunotherapy
AT jiaoyang newmouseesophagealcancercelllinemec25derivedpreclinicalsyngeneictumormodelforimmunotherapy
AT beileiliu newmouseesophagealcancercelllinemec25derivedpreclinicalsyngeneictumormodelforimmunotherapy
AT lifu newmouseesophagealcancercelllinemec25derivedpreclinicalsyngeneictumormodelforimmunotherapy
_version_ 1724693803696128000